Hydrogen Water Protects Brain After Injury in Mouse Study

Authors
Journal
Experimental and Therapeutic Medicine
Year
DOI
10.3892/etm.2021.11049
Study Type
Mouse
Outcome
Positive
Peer Reviewed
Yes
Country
China
Health Condition
Traumatic Brain Injury
Body System
Nervous System

TL;DR

A study found that injecting mice with hydrogen-rich saline after a brain injury can improve brain function and reduce brain cell death.

Key Finding

Hydrogen-rich saline treatment improved neurological outcomes and reduced neuronal death in mice with traumatic brain injury by suppressing necroptosis (a form of cell death) and inflammatory responses.

Summary

Researchers tested whether hydrogen-rich saline (a salt solution containing dissolved hydrogen gas) could protect brain cells in mice with traumatic brain injury. They found that the treatment improved neurological function, reduced brain swelling, decreased harmful molecules called free radicals, and prevented a type of cell death called necroptosis. The protective effects appeared to work through a specific cellular pathway involving antioxidant proteins.

Practical Takeaway

This early-stage mouse study suggests hydrogen-rich saline may have neuroprotective potential for traumatic brain injury, but these results cannot yet be applied to humans. Further research in larger animal models and human clinical trials would be needed to determine whether this approach could be effective and safe for brain injury patients.

Abstract

Traumatic brain injury (TBI) has been recognized as a serious public health issue and a key contributor to disability and death, with a huge economic burden worldwide. Hydrogen, which is a slight and specific cytotoxic oxygen radical scavenger, has been demonstrated to ameliorate early brain injury (EBI) through reactive oxygen species (ROS), oxidative stress injury, apoptosis and necroptosis. Necroptosis refers to a type of programmed cell death process that has a vital function in neuronal cell death following TBI. The specific function of necroptosis in hydrogen-mediated neuroprotection after TBI, however, has yet to be determined. The present study aimed to examine the neuroprotective effects and possible molecular basis that underly hydrogen-rich saline in TBI-stimulated EBI by examining neural necroptosis in the C57BL/6 mouse model. The brain water content, neurological score, neuroinflammatory cytokines (NF-κΒ, TNF-α, IL-6 and IL-1β) and ROS were evaluated using flow cytometry. Malondialdehyde, superoxide dismutase (SOD) and glutathione (GSH) levels were evaluated using a biochemical kit. Receptor-interacting protein kinase (RIP)1, RIP3, Nrf2 and Heme oxygenase-1 (HO-1) were evaluated using western blotting. mRNA of Nrf2 and HO-1 were evaluated using quantitative PCR. Neuronal death was evaluated by TUNEL staining. The outcomes illustrated that hydrogen-rich saline treatment considerably enhanced the neurological score, increased neuronal survival, decreased the levels of serum MDA and brain ROS, increased the levels of serum GSH and SOD. In addition the protein expression levels of RIP1 and RIP3 and the cytokines NF-κB, TNF-α, IL-1β and IL-6 were downregulated compared with the TBI group, which demonstrated that hydrogen-rich saline-induced inhibition of necroptosis and neuroinflammation ameliorated neuronal death following TBI. The neuroprotective capacity of hydrogen-rich saline was demonstrated to be partly dependent on the ROS/heme oxygenase-1 signaling pathway. Taken together, the findings of the present study indicated that hydrogen-rich saline enhanced neurological outcomes in mice and minimized neuronal death by inducing protective effects against neural necroptosis as well as neuroinflammation.